Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Zenyaku Kogyo receives license to Theraclone Sciences' influenza monoclonal antibody program

Theraclone Sciences, Inc., announced that Zenyaku Kogyo Co. Ltd., has exercised its option for an exclusive license in the Japan territory to Theraclone’s influenza monoclonal antibody program. The collaboration utilizes Theraclone’s I-STAR™ technology to discover broadly protective monoclonal antibodies for the treatment of pandemic influenza and severe seasonal influenza.

22 Mar 2010

Vical awarded contract to conduct Phase 1 clinical trial of Vaxfectin-formulated DNA vaccine against A/H1N1

Vical Incorporated announced today that the U.S. Navy, through the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., has awarded Vical a contract to conduct a Phase 1 clinical trial of the company's Vaxfectin®-formulated DNA vaccine against A/H1N1 pandemic influenza (swine flu).

22 Mar 2010

Researchers develop new compound to inhibit HIV transmission

A compound that can inhibit the transfer of HIV from one cell to another has been developed by researchers at the Institut de Biologie Structurale Jean-Pierre Ebel.

22 Mar 2010

Swine flu risk to pregnant women uncovered in landmark study

A study to be published in the British Medical Journal (BMJ) today has found 11 percent of pregnant women admitted to intensive care units (ICU) with 2009 A/H1N1 (swine flu) died, with 12 percent of babies born to them dying from complications. None of the mothers had been immunised against seasonal flu.

22 Mar 2010

Influenza pandemic policies: WHO denies being improperly influenced by pharmaceutical industry

Providing independent advice to Member States is a very important function of the World Health Organization (WHO). We take this work seriously and guard against the influence of any improper interests. The WHO influenza pandemic policies and response have not been improperly influenced by the pharmaceutical industry.

20 Mar 2010

Gradual reduction in smoking as successful as abrupt quitting

Although many smokers try to quit by selecting a "quit day" and going cold turkey, a new Cochrane review finds that quitting gradually might work just as well.

20 Mar 2010

SHEA, APIC awarded first Partnership in Prevention Award to National Guard Health Affairs in Saudi Arabia

During the Fifth Decennial International Conference on Healthcare-Associated Infections, the Society for Healthcare Epidemiology of America and the Association for Professionals in Infection Control and Epidemiology awarded their first Partnership in Prevention Award to the National Guard Health Affairs in Saudi Arabia.

20 Mar 2010

ITDS can be effective for screening fever during H1N1 influenza pandemic: UNMC researchers

Researchers at the University of Nebraska Medical Center found an Infrared Thermal Detection System to be a fast and effective fever screening tool in clinical settings during the H1N1 influenza pandemic. The ITDS detected fever in patients through split-second, non-contact skin temperature measurements.

20 Mar 2010

Novus Scientific's TIGR Matrix Surgical Mesh: Initial results of First-in-Man study

Novus Scientific Pte. Ltd today announced the presentation of initial results of the First-in-Man study for TIGR™ Matrix Surgical Mesh. The study results were presented today at the American Hernia Society Meeting in Orlando, Florida by Dr. Fernando Ruiz-Jasbon, Consultant Surgeon at Kungsbacka Hospital / Gothenburg University, Sweden.

20 Mar 2010

Safe to smoke?

Some Australian scientists have found that there is a new agent that can protect the lungs of mice from the harmful effects of cigarette smoke.

19 Mar 2010

Reese Pharmaceutical chooses SYSPRO ERP for private labeling and distribution operations

SYSPRO, the leading provider of visionary, pragmatic ERP software, today announced that Reese Pharmaceutical Company has selected SYSPRO ERP (Enterprise Resource Planning) software to run its private labeling and distribution operations. Reese, based in Cleveland, Ohio, has been in business for more than a century.

19 Mar 2010

Pressure BioSciences announces presentations on advantages of PCT

Pressure BioSciences, Inc. today announced that five presentations on the advantages of pressure cycling technology (PCT) in the preparation, processing, identification, and quantification of proteins were made at last week's annual meeting of US HUPO (Human Proteomics Organization) in Denver, Colorado.

From Thermo Fisher Scientific Inc. 19 Mar 2010

Activeion Cleaning Solutions announces new European subsidiary, Activeion GmbH

Activeion Cleaning Solutions LLC, Rogers, MN USA is proud to announce its new European subsidiary, Activeion (Europe) GmbH. Activeion (Europe) GmbH will distribute and market the ionator EXP™ throughout Europe, the Middle East and Africa. Activeion's ionator EXP™ is a handheld, on-demand, completely chemical-free cleaning tool that activates and converts tap water into ionised water, a powerful dirt-removing and bacteria-killing product.

19 Mar 2010

Propeller tears right arm, UT Southwestern Medical Center surgeon re-attaches

"The propeller cut through the skin, muscle, tendons and bone and had removed portions of the bone," he recalled. "Basically, she had severed her arm, and it was attached only by some skin, tendon, nerve and artery."

19 Mar 2010

CHMP issues positive opinion recommending approval of Tarceva as monotherapy for NSCLC

OSI Pharmaceuticals, Inc. announced today that its international partner for Tarceva® (erlotinib), Roche, informed OSI that the European Committee for Medicinal Products for Human Use has issued a positive opinion recommending approval of Tarceva as monotherapy for maintenance treatment in patients with locally advanced or metastatic non-small cell lung cancer with stable disease following four cycles of standard platinum-based first-line chemotherapy.

19 Mar 2010

Genes role in protecting intestinal tract from colitis may lead to potential targets for treatment

Scientists report a protein made by a gene already associated with a handful of human inflammatory immune diseases plays a pivotal role in protecting the intestinal tract from colitis.

19 Mar 2010

Implementation of evidenced-based practices reduces all healthcare-associated MRSA infections

Scientists at The Virginia Commonwealth University Medical Center found that an emphasis on compliance with non-pathogen specific infection control practices such as hand hygiene, efforts to reduce device-related infections and chlorhexidine bathing (a daily bath with the same antibacterial agent used by surgeons to "scrub in" before an operation), is successful in reducing rates of healthcare-associated methicillin-resistant Staphylococcus aureus.

19 Mar 2010

Noscapine can be used as prophylactic treatment for prostate cancer: Study

New research has revealed a major breakthrough in the use of cough medicine ingredient noscapine as a prophylactic treatment for prostate cancer.

19 Mar 2010

FDA categorizes Nanosphere's RVNATSP assay on Verigene SP System as "Moderate Complexity"

Nanosphere, Inc., a leader in the development and commercialization of advanced molecular diagnostics systems, received notification from the U.S. Food and Drug Administration (FDA) that its respiratory virus panel (RVNATSP) performed on the Verigene SP System has been categorized as "Moderate Complexity" under the Clinical Laboratory Improvement Amendments of 1988 (CLIA).

19 Mar 2010

Overall mortality rates at Bay Medical Center in Panama City drop 1.3 points

Overall mortality rates from the end of 2007 to the beginning of 2010 at Bay Medical Center in Panama City, Florida have dropped from 3.4 to 2.1. A 1.3-point drop represents a huge reduction for any hospital and translates into lives saved.

19 Mar 2010

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Zenyaku Kogyo receives license to Theraclone Sciences' influenza monoclonal antibody program

Vical awarded contract to conduct Phase 1 clinical trial of Vaxfectin-formulated DNA vaccine against A/H1N1

Researchers develop new compound to inhibit HIV transmission

Swine flu risk to pregnant women uncovered in landmark study

Influenza pandemic policies: WHO denies being improperly influenced by pharmaceutical industry

Gradual reduction in smoking as successful as abrupt quitting

SHEA, APIC awarded first Partnership in Prevention Award to National Guard Health Affairs in Saudi Arabia

ITDS can be effective for screening fever during H1N1 influenza pandemic: UNMC researchers

Novus Scientific's TIGR Matrix Surgical Mesh: Initial results of First-in-Man study

Safe to smoke?

Reese Pharmaceutical chooses SYSPRO ERP for private labeling and distribution operations

Pressure BioSciences announces presentations on advantages of PCT

Activeion Cleaning Solutions announces new European subsidiary, Activeion GmbH

Propeller tears right arm, UT Southwestern Medical Center surgeon re-attaches

CHMP issues positive opinion recommending approval of Tarceva as monotherapy for NSCLC

Genes role in protecting intestinal tract from colitis may lead to potential targets for treatment

Implementation of evidenced-based practices reduces all healthcare-associated MRSA infections

Noscapine can be used as prophylactic treatment for prostate cancer: Study

FDA categorizes Nanosphere's RVNATSP assay on Verigene SP System as "Moderate Complexity"

Overall mortality rates at Bay Medical Center in Panama City drop 1.3 points

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in